Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study

被引:12
|
作者
Peng, Juan [1 ]
Zhang, Yan [2 ,3 ]
Zhu, Yiqun [2 ]
Chen, Weilin [1 ,4 ]
Chen, Li [1 ,4 ]
Ma, Fangyu [5 ]
Yi, Bin [1 ,4 ]
Huang, Zhijun [1 ,4 ,6 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Branch Natl Clin Res Ctr Resp Dis, Dept Resp Med,Natl Key Clin Specialty, Changsha, Hunan, Peoples R China
[3] Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China
[4] Clin Res Ctr Crit Kidney Dis Hunan Prov, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China
[6] Furong Lab, Changsha, Hunan, Peoples R China
来源
BMC MEDICINE | 2024年 / 22卷 / 01期
关键词
Estimated glucose disposal rate; Chronic kidney disease; Cardiovascular events; Mortality; INSULIN-RESISTANCE; INFLAMMATION; ASSOCIATION; MUSCLE;
D O I
10.1186/s12916-024-03582-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Evidence suggests that insulin resistance (IR) is an autonomous risk factor for cardiovascular disease (CVD). Nevertheless, the association between estimated glucose disposal rate (eGDR), a novel indicator of IR, and incident CVD and mortality in chronic kidney disease (CKD) patients without diabetes remains uncertain. Methods The study included 19,906 participants from the UK Biobank who had an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m(2) or a urinary albumin-to-creatinine ratio (UACR) >= 30 mg/g and no history of CVD and diabetes. Individuals were divided into three categories based on tertiles of eGDR. The outcome was a composite CVD (coronary heart disease (CHD) and stroke) and mortality (all-cause, non-accidental, and cardiovascular mortality). Furthermore, a cohort of 1,600 individuals from the US National Health and Nutrition Examination Survey (NHANES) was applied to validate the association between eGDR and mortality. The Cox proportional hazards regression models were used to examine the association between eGDR and event outcomes. Results During a follow-up of around 12 years, 2,860 CVD, 2,249 CHD, 783 stroke, 2,431 all-cause, 2,326 non-accidental and 492 cardiovascular deaths were recorded from UK Biobank. Higher eGDR level was not only associated with lower risk of CVD (hazard ratio [HR] 0.641, 95% confidence interval [CI] 0.559-0.734), CHD (HR 0.607, 95% CI 0.520-0.709), stroke (HR 0.748, 95% CI 0.579-0.966), but also related to reduced risk of all-cause (HR 0.803, 95% CI 0.698-0.923), non-accidental (HR 0.787, 95% CI 0.682-0.908), and cardiovascular mortality (HR 0.592, 95% CI 0.423-0.829). Validation analyses from NHANES yielded consistent relationship on mortality. Conclusions In these two large cohorts of CKD patients without DM, a higher eGDR level was associated with a decreased risk of CVD and mortality.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Prognostic Value of Estimated Glucose Disposal Rate and Systemic Immune-Inflammation Index in Non-Diabetic Patients Undergoing PCI for Chronic Total Occlusion
    Chen, Wenjie
    Liu, Yiming
    Shi, Yuchen
    Liu, Jinghua
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (09)
  • [22] Mortality and cardiovascular events increased in non-diabetic subjects with metabolic syndrome; fasting glucose a strong predictor of increased mortality: A PreCIS database cohort study
    Doshi, Krupa B.
    Brennan, Danielle M.
    Hoar, Brian M.
    Hoogwerf, Byron J.
    Cho, Leslie
    Kashyap, Sangeeta R.
    DIABETES, 2007, 56 : A255 - A255
  • [23] Predicting cardiovascular mortality in chronic kidney disease (CKD) patients
    Sun, Wenhui
    Liu, Dahai
    Gong, Ping
    Shi, Xiaoyu
    Wang, Yong
    Wang, Ping
    Gong, Weihua
    ANNALS OF TRANSPLANTATION, 2014, 19
  • [24] Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease
    Akira Mima
    Advances in Therapy, 2021, 38 : 2201 - 2212
  • [25] Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease
    Mima, Akira
    ADVANCES IN THERAPY, 2021, 38 (05) : 2201 - 2212
  • [26] PROGNOSTIC VALUE OF MICROALBUMINURIA FOR PREDICTING KIDNEY DISEASE PROGRESSION IN NON-DIABETIC HYPERTENSIVE PATIENTS: A 7 YEARS COHORT STUDY
    Pongsathorn, Gojaseni
    Angkana, Phaopha
    Worawon, Chailimpamontree
    Anutra, Chittinandana
    NEPHROLOGY, 2014, 19 : 64 - 65
  • [27] Ceramides Surpass LDL-Cholesterol in Predicting Cardiovascular Mortality in Diabetic and Non-Diabetic Patients
    Leiherer, Andreas
    Muendlein, Axel
    Saely, Christoph H.
    Plattner, Thomas
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Laaksonen, Reijo
    Fraunberger, Peter
    Drexel, Heinz
    CIRCULATION, 2024, 150
  • [28] Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study
    van Keulen, Kris
    Knol, Wilma
    Belitser, Svetlana, V
    Zaal, Irene J.
    van der Linden, Paul D.
    Heerdink, Eibert R.
    Egberts, Toine C. G.
    Slooter, Arjen J. C.
    PLOS ONE, 2018, 13 (11):
  • [29] Impact of triglyceride-glucose index on risk of cardiovascular disease among non-diabetic hypertension patients: a 10-year prospective cohort study
    Chen, Xin
    Yang, Jinyou
    Wang, Dan
    Liu, Jiali
    Jin, Hang
    Zhang, Yongqing
    Xiang, Quanyong
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [30] Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease (vol 15, pg 1705, 2022)
    Quiroga, Borja
    Ramos, Patricia Munoz
    Horrillo, Ana Sanchez
    Ortiz, Alberto
    Valdivielso, Jose Manuel
    Carrero, Juan Jesus
    CLINICAL KIDNEY JOURNAL, 2023, 16 (05) : 883 - 883